Finding a treatment for MS has been a powerful allure for many medical entities. Investigations into treatment strategies originate from pharma-sponsored academic researchers all the way through to pseudo-scientists and esoteric holistic healers who practise on the edges of medicine. MS is a compelling target for research not only because of its fast-growing patient population, but because of the ability to easily affect the symptoms of MS by applying considerably different therapeutic strategies to treatment modalities. The success in reducing MS symptoms as a result of applying so many different approaches leads many researchers down rabbit holes that ultimately do not direct us towards a cure. Dreadful side-effects sometimes accompany these therapies, especially the pharma-based medications. Incredible financial rewards await a cure, but the drug companies are doing their best to maintain the status quo. They are no longer even pretending to look for a cure. As the entrenched incumbents who control the entire medical system world-wide, they privately and secretly argue behind board room doors that whether they can or not, it’s financial folly to do so. It’s much more profitable to keep patients on medications for decades while they fend off, and attempt to discredit other promising therapeutic strategies from other clinical investigators that might actually work. In this respect, the slow-moving disease process of MS makes for their ‘dream disease’, and the drug companies own the entire domain.
